The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Marco Metra

Institute of Cardiology

University of Brescia

c/o Spedali Civili di Brescia

Piazzale Spedali Civili 1

Italy

[email]@libero.it

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Institute of Cardiology, University of Brescia, c/o Spedali Civili di Brescia, Piazzale Spedali Civili 1, Italy. 2004 - 2012
  • Cardiology, Department of Experimental and Applied Medicine, University and Civil Hospital of Brescia, c/o Spedali Civili, Italy. 2006 - 2012
  • Institute of Cardiology, University of Brescia, Brescia, Italy. 2000 - 2012

References

  1. The role of the kidney in heart failure. Metra, M., Cotter, G., Gheorghiade, M., Dei Cas, L., Voors, A.A. Eur. Heart J. (2012) [Pubmed]
  2. Troponin T levels in patients with acute heart failure: clinical and prognostic significance of their detection and release during hospitalisation. Metra, M., Bettari, L., Pagani, F., Lazzarini, V., Lombardi, C., Carubelli, V., Bonetti, G., Bugatti, S., Parrinello, G., Caimi, L., Felker, G.M., Dei Cas, L. Clin. Res. Cardiol (2012) [Pubmed]
  3. The puzzle of kidney dysfunction in heart failure: an introduction. Metra, M., Voors, A.A. Heart. Fail. Rev (2012) [Pubmed]
  4. Use of inotropic agents in patients with advanced heart failure: lessons from recent trials and hopes for new agents. Metra, M., Bettari, L., Carubelli, V., Bugatti, S., Dei Cas, A., Del Magro, F., Lazzarini, V., Lombardi, C., Dei Cas, L. Drugs (2011) [Pubmed]
  5. Can we improve the treatment of congestion in heart failure? Metra, M., Bugatti, S., Bettari, L., Carubelli, V., Danesi, R., Lazzarini, V., Lombardi, C., Cas, L.D. Expert. Opin. Pharmacother (2011) [Pubmed]
  6. Dyspnoea and worsening heart failure in patients with acute heart failure: results from the Pre-RELAX-AHF study. Metra, M., Teerlink, J.R., Felker, G.M., Greenberg, B.H., Filippatos, G., Ponikowski, P., Teichman, S.L., Unemori, E., Voors, A.A., Weatherley, B.D., Cotter, G. Eur. J. Heart Fail. (2010) [Pubmed]
  7. Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failure. Metra, M., Covolo, L., Pezzali, N., Zacà, V., Bugatti, S., Lombardi, C., Bettari, L., Romeo, A., Gelatti, U., Giubbini, R., Donato, F., Dei Cas, L. Cardiovasc. Drugs. Ther (2010) [Pubmed]
  8. Vasodilators in the treatment of acute heart failure: what we know, what we don't. Metra, M., Teerlink, J.R., Voors, A.A., Felker, G.M., Milo-Cotter, O., Weatherley, B., Dittrich, H., Cotter, G. Heart. Fail. Rev (2009) [Pubmed]
  9. Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials. Metra, M., Eichhorn, E., Abraham, W.T., Linseman, J., Böhm, M., Corbalan, R., DeMets, D., De Marco, T., Elkayam, U., Gerber, M., Komajda, M., Liu, P., Mareev, V., Perrone, S.V., Poole-Wilson, P., Roecker, E., Stewart, J., Swedberg, K., Tendera, M., Wiens, B., Bristow, M.R. Eur. Heart J. (2009) [Pubmed]
  10. Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. Metra, M., Nodari, S., Parrinello, G., Bordonali, T., Bugatti, S., Danesi, R., Fontanella, B., Lombardi, C., Milani, P., Verzura, G., Cotter, G., Dittrich, H., Massie, B.M., Dei Cas, L. Eur. J. Heart Fail. (2008) [Pubmed]
  11. The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T. Metra, M., Nodari, S., Parrinello, G., Specchia, C., Brentana, L., Rocca, P., Fracassi, F., Bordonali, T., Milani, P., Danesi, R., Verzura, G., Chiari, E., Dei Cas, L. Eur. J. Heart Fail. (2007) [Pubmed]
  12. Advanced chronic heart failure: A position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology. Metra, M., Ponikowski, P., Dickstein, K., McMurray, J.J., Gavazzi, A., Bergh, C.H., Fraser, A.G., Jaarsma, T., Pitsis, A., Mohacsi, P., Böhm, M., Anker, S., Dargie, H., Brutsaert, D., Komajda, M. Eur. J. Heart Fail. (2007) [Pubmed]
  13. Should beta-blocker therapy be reduced or withdrawn after an episode of decompensated heart failure? Results from COMET. Metra, M., Torp-Pedersen, C., Cleland, J.G., Di Lenarda, A., Komajda, M., Remme, W.J., Dei Cas, L., Spark, P., Swedberg, K., Poole-Wilson, P.A. Eur. J. Heart Fail. (2007) [Pubmed]
  14. Beta-blocker therapy of heart failure: an update. Metra, M., Nodari, S., Bordonali, T., Milani, P., Fracassi, F., Dei Cas, L. Expert. Opin. Pharmacother (2007) [Pubmed]
  15. Clinical trials update from the World Congress of Cardiology 2006. Metra, M., Nodari, S., Bordonali, T., Milani, P., Dei Cas, L. Expert. Opin. Pharmacother (2007) [Pubmed]
  16. Role of beta1- and alpha2c-adrenergic receptor polymorphisms and their combination in heart failure: a case-control study. Metra, M., Zani, C., Covolo, L., Nodari, S., Pezzali, N., Gelatti, U., Donato, F., Nardi, G., Dei Cas, L. Eur. J. Heart Fail. (2006) [Pubmed]
  17. Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial. Metra, M., Torp-Pedersen, C., Swedberg, K., Cleland, J.G., Di Lenarda, A., Komajda, M., Remme, W.J., Lutiger, B., Scherhag, A., Lukas, M.A., Charlesworth, A., Poole-Wilson, P.A. Eur. Heart J. (2005) [Pubmed]
  18. Beta-blockers in heart failure: are pharmacological differences clinically important?. Metra, M., Cas, L.D., di Lenarda, A., Poole-Wilson, P. Heart. Fail. Rev (2004) [Pubmed]
  19. Current guidelines in the pharmacological management of chronic heart failure. Metra, M., Nodari, S., Dei Cas, L. J. Renin. Angiotensin. Aldosterone. Syst (2004) [Pubmed]
  20. Marked improvement in left ventricular ejection fraction during long-term beta-blockade in patients with chronic heart failure: clinical correlates and prognostic significance. Metra, M., Nodari, S., Parrinello, G., Giubbini, R., Manca, C., Dei Cas, L. Am. Heart J. (2003) [Pubmed]
  21. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol. Metra, M., Nodari, S., D'Aloia, A., Muneretto, C., Robertson, A.D., Bristow, M.R., Dei Cas, L. J. Am. Coll. Cardiol. (2002) [Pubmed]
  22. Beta-blockade in heart failure: selective versus nonselective agents. Metra, M., Nodari, S., Dei Cas, L. Am. J. Cardiovasc. Drugs (2001) [Pubmed]
  23. Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol. Metra, M., Giubbini, R., Nodari, S., Boldi, E., Modena, M.G., Dei Cas, L. Circulation (2000) [Pubmed]
 
WikiGenes - Universities